HBB rs334: Understanding the Sickle Cell Variant
The rs334 variant in the HBB gene is a well-studied genetic change that alters the structure of hemoglobin. Depending on whether an individual inherits one or two copies of this variant, it is associated with sickle cell trait or sickle cell disease.
What each genotype means
Typical hemoglobin profile
This genotype represents the standard, non-sickling form of the hemoglobin beta gene. Individuals with this genotype do not carry the sickle cell trait or have sickle cell disease associated with this specific variant.
This is the most common genotype globally, found in the vast majority of the human population.
Sickle cell trait carrier
Individuals with this genotype are carriers of the sickle cell trait, meaning they possess one copy of the typical hemoglobin gene and one copy of the sickling hemoglobin gene. Research indicates that carriers are generally unaffected by sickle cell disease but may have increased resistance to severe malaria in regions where it is endemic.
This genotype is most frequently observed in populations with ancestry from sub-Saharan Africa, the Mediterranean, and parts of India.
Sickle cell disease
This genotype is associated with sickle cell disease, a condition where the body produces abnormal hemoglobin that can cause red blood cells to become rigid and sickle-shaped. Individuals with this genotype should consult with a healthcare professional or genetic counselor to discuss clinical management and care.
This genotype is rare globally but occurs at higher frequencies in specific populations where the sickle cell trait is prevalent due to historical evolutionary pressure from malaria.
What is the rs334 Variant?
The rs334 variant, often referred to as the HbS allele, is a single nucleotide polymorphism (SNP) located in the HBB gene on chromosome 11. Specifically, it involves a substitution of the nucleotide adenine (A) with thymine (T) at a specific position, which results in a change in the protein sequence. This mutation causes the substitution of the amino acid valine for glutamic acid at the sixth or seventh position of the beta-globin chain, depending on the nomenclature used. This structural change is significant because it alters the physical properties of hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. When oxygen levels are low, hemoglobin containing this variant can cause red blood cells to take on a rigid, sickle-like shape, which can impact blood flow and lead to various clinical manifestations.
The Role of the HBB Gene
The HBB gene provides instructions for making a protein called beta-globin, which is a crucial component of hemoglobin. Hemoglobin is a complex protein found in red blood cells that binds to oxygen in the lungs and releases it into tissues throughout the body. In healthy individuals, hemoglobin is composed of two alpha-globin chains and two beta-globin chains. The HBB gene is essential for the proper assembly and function of these beta-globin chains. When mutations occur in this gene, they can lead to hemoglobinopathies, a group of disorders that affect the structure or production of hemoglobin. The rs334 variant is the most common pathogenic mutation in this gene, fundamentally changing how hemoglobin behaves under physiological stress. Understanding the function of the HBB gene is key to grasping why even a single nucleotide change can have such profound effects on human health.
Research and Clinical Associations
Research has firmly established that the rs334 variant is the primary cause of sickle cell disease when inherited in a homozygous state (two copies of the variant). Individuals who inherit one copy of the variant (heterozygous) typically have sickle cell trait, which is generally asymptomatic but can have implications under extreme physiological conditions. Clinical evidence from databases like ClinVar classifies this variant as pathogenic. Beyond the primary diagnosis of sickle cell disease, recent studies have explored associations between this variant and other health outcomes, such as susceptibility to pneumonia in specific populations. It is important to note that while the association with sickle cell disease is well-defined, the clinical expression of the condition can be highly variable between individuals. Genetic research continues to investigate how other genetic and environmental factors influence the severity and presentation of symptoms in those who carry the rs334 variant.
Population Frequency
The frequency of the rs334 variant varies significantly across different global populations, largely due to historical evolutionary pressures related to malaria. The variant is found at its highest frequencies in populations with ancestry from sub-Saharan Africa, the Mediterranean, and parts of India. In many African and African American populations, the variant reaches polymorphic frequencies, often exceeding 1% and sometimes reaching much higher levels in specific regions. This high prevalence is attributed to the protective effect that the heterozygous state (sickle cell trait) provides against severe malaria. Because of this evolutionary history, the variant is much less common in populations without these ancestral backgrounds. Large-scale genomic databases like gnomAD provide detailed insights into these frequency distributions, confirming that while the variant is rare globally, it is a significant health consideration for specific ancestral groups.
Interpreting Your Genetic Information
If you have information regarding your status for the rs334 variant, it is important to understand what this means in a medical context. This information is not a diagnosis and should not be used to make personal health decisions without professional guidance. If you are concerned about your carrier status or potential health risks, you should consult with a healthcare provider or a genetic counselor. They can provide context based on your personal and family medical history, explain the implications of your genotype, and discuss appropriate testing or screening options. For individuals who may be managing a condition related to this variant, always discuss any medication or treatment plans with your clinician or pharmacist. Genetic information is a tool for health management, but it must be interpreted within the broader context of your overall health and clinical care.
How common is this variant?
The rs334 variant reaches polymorphic frequency (>1%) in populations of African and African American ancestry, where it is most prevalent due to historical evolutionary selection.
Frequently asked questions
What is the difference between sickle cell trait and sickle cell disease?
Sickle cell trait occurs when an individual inherits one copy of the HbS variant, usually resulting in no symptoms. Sickle cell disease occurs when an individual inherits two copies of the variant, which can lead to chronic health complications.
Is the rs334 variant the only cause of sickle cell disease?
While rs334 is the most common cause, sickle cell disease can also result from inheriting the HbS variant in combination with other hemoglobin variants, such as Hemoglobin C or beta-thalassemia.
Why is the rs334 variant common in certain populations?
The variant is common in regions where malaria is or was historically endemic. Carrying one copy of the variant provides a survival advantage against severe malaria, which helped the variant persist in these populations.
Can I be tested for the rs334 variant?
Yes, clinical testing for the HBB gene is available through healthcare providers. If you are interested in testing, consult your doctor or a genetic counselor to discuss the appropriateness of the test for your situation.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs334?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a pathogenic mutation in the HBB gene associated with beta-thalassemia.
This variant is a pathogenic mutation in the HBB gene associated with hemoglobinopathies such as sickle cell disease.
Pathogenic variant (p.Glu6Val, HbS-Antilles) in HBB associated with sickle cell disease-like pathology.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.
A variant in the HBB gene linked to beta-thalassemia carrier status.